The ovarian cancer TME is particularly immunosuppressive with high levels of immunoregulatory mediators such as PGE2, IL-10, VEGF and others, all correlating with tumor progression and poor prognosis [102]. The gene discussed is VEGFA; the disease is ovarian carcinoma.